Dr. Stefan Knackmuss

Dr. Stefan Knackmuss has extensive experience in preclinical development. Dr. Stefan currently serves as the Vice President of Preclinical Development at LTZ Therapeutics, a position they have held since December 2022. Prior to this, they worked at Affimed Therapeutics AG for over 20 years, where they held the role of Head of Preclinical Development. During their tenure at Affimed Therapeutics AG, they played a crucial role in the company's preclinical development efforts.

Dr. Stefan Knackmuss attended Heidelberg University for their education, although the exact years and degree obtained are unknown. The field of study pursued by Dr. Knackmuss is also unspecified.